Hepatitis B virus (HBV) reactivation is a well-known complication related to immunosuppression. Clinical manifestations of HBV relapse range from self-limiting anicteric hepatitis to acute hepatic failure. Temozolomide (TMZ) is an alkylating agent used for the treatment of glioblastoma multiforme (GBM), the most common and deadliest of malignant primary brain tumors.

Glioblastoma multiforme and hepatitis B: do the right thing(s) / Purchiaroni, F; Begini, Paola; Minniti, G; Gallina, S; DELLE FAVE, Gianfranco; Marignani, M.. - In: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES. - ISSN 2284-0729. - STAMPA. - 18:23(2014), pp. 3629-3631.

Glioblastoma multiforme and hepatitis B: do the right thing(s)

BEGINI, PAOLA;DELLE FAVE, Gianfranco;
2014

Abstract

Hepatitis B virus (HBV) reactivation is a well-known complication related to immunosuppression. Clinical manifestations of HBV relapse range from self-limiting anicteric hepatitis to acute hepatic failure. Temozolomide (TMZ) is an alkylating agent used for the treatment of glioblastoma multiforme (GBM), the most common and deadliest of malignant primary brain tumors.
Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Glioblastoma; Hepatitis B; Hepatitis B virus; Humans; Male; Middle Aged; Virus Activation
01 Pubblicazione su rivista::01a Articolo in rivista
Glioblastoma multiforme and hepatitis B: do the right thing(s) / Purchiaroni, F; Begini, Paola; Minniti, G; Gallina, S; DELLE FAVE, Gianfranco; Marignani, M.. - In: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES. - ISSN 2284-0729. - STAMPA. - 18:23(2014), pp. 3629-3631.
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/833176
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 3
social impact